The latest updates from Dr Li-Anne Lim’s groundbreaking Australian site for the IDEAYA Biosciences trial are in. This trial focuses on the use of neoadjuvant Darovasertib in the treatment of uveal melanoma, a rare and aggressive form of eye cancer. With a total of 10 patients actively participating in the trial, the team is aiming to make significant strides in …